Repligen Corporation Peer Comparison
Metric | Value | Ranking | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $8.4 Billion | 8/14 | ISRG $206.1B |
BDX $64.8B |
RMD $34.7B |
WST $23.3B |
COO $18.4B |
HOLX $14.3B |
ATR $9.4B |
RGEN $8.4B |
TFX $7.8B |
MMSI $6.3B |
ICUI $3.8B |
NVST $3.6B |
HAE $3.1B |
ANGO $423.3M |
Gross Margin | 26% | 13/14 | BDX 100% |
ISRG 67% |
COO 67% |
RMD 59% |
HOLX 57% |
HAE 56% |
TFX 56% |
ANGO 55% |
NVST 53% |
MMSI 46% |
WST 35% |
ICUI 35% |
RGEN 26% |
ATR -41% |
Profit Margin | 13% | 6/14 | ISRG 28% |
RMD 25% |
HOLX 20% |
WST 18% |
TFX 15% |
RGEN 13% |
COO 12% |
HAE 11% |
ATR 11% |
BDX 8% |
MMSI 8% |
NVST 1% |
ICUI -6% |
ANGO -15% |
EBITDA margin | 3% | 12/14 | ATR 182% |
RMD 36% |
HOLX 34% |
ISRG 28% |
WST 22% |
MMSI 22% |
COO 19% |
HAE 17% |
TFX 15% |
BDX 12% |
NVST 10% |
RGEN 3% |
ICUI 1% |
ANGO -3% |
Quarterly Revenue | $141.2 Million | 13/14 | BDX $5.4B |
ISRG $2.0B |
RMD $1.2B |
HOLX $1.0B |
COO $1.0B |
ATR $909.3M |
TFX $764.4M |
WST $746.9M |
NVST $601.0M |
ICUI $589.1M |
HAE $348.5M |
MMSI $339.8M |
RGEN $141.2M |
ANGO $72.8M |
Quarterly Earnings | $18.2 Million | 11/14 | ISRG $565.1M |
BDX $421.0M |
RMD $311.4M |
HOLX $201.0M |
WST $136.0M |
COO $117.5M |
TFX $111.0M |
ATR $100.0M |
HAE $37.5M |
MMSI $28.4M |
RGEN $18.2M |
NVST $8.2M |
ANGO -$10.7M |
ICUI -$33.0M |
Quarterly Free Cash Flow | -$71.1 Million | 12/14 | ISRG $1.5B |
WST $370.9M |
TFX $306.6M |
RMD $305.9M |
HOLX $172.5M |
ATR $153.8M |
NVST $63.3M |
MMSI $37.4M |
HAE $35.2M |
ICUI $21.6M |
ANGO $1.7M |
RGEN -$71.1M |
BDX -$0 |
COO -$0 |
Trailing 4 Quarters Revenue | $602.4 Million | 13/14 | BDX $20.2B |
ISRG $7.9B |
RMD $4.8B |
HOLX $4.0B |
ATR $3.6B |
TFX $3.0B |
COO $3.0B |
WST $2.9B |
NVST $2.8B |
ICUI $2.3B |
HAE $1.4B |
MMSI $1.3B |
RGEN $602.4M |
ANGO $286.5M |
Trailing 4 Quarters Earnings | -$1.9 Million | 11/14 | BDX $5.4B |
ISRG $2.0B |
RMD $1.2B |
HOLX $1.0B |
COO $1.0B |
ATR $909.3M |
TFX $764.4M |
WST $746.9M |
NVST $601.0M |
ICUI $589.1M |
HAE $348.5M |
MMSI $339.8M |
RGEN $141.2M |
ANGO $72.8M |
Quarterly Earnings Growth | 0% | 9/14 | BDX 173% |
ANGO 63% |
RMD 42% |
COO 39% |
ISRG 36% |
HAE 20% |
ATR 19% |
MMSI 10% |
RGEN 0% |
WST -16% |
HOLX -18% |
TFX -19% |
NVST -62% |
ICUI -556% |
Annual Earnings Growth | -102% | 11/14 | HOLX 44% |
MMSI 39% |
ISRG 34% |
BDX 26% |
RMD 23% |
HAE 23% |
COO 15% |
ATR 1% |
WST -20% |
TFX -50% |
RGEN -102% |
ANGO -307% |
ICUI -392% |
NVST -855% |
Quarterly Revenue Growth | 0% | 11/14 | HOLX 268% |
RMD 27% |
ISRG 17% |
COO 10% |
MMSI 8% |
BDX 7% |
ICUI 6% |
HAE 4% |
TFX 2% |
ATR 2% |
RGEN 0% |
WST 0% |
NVST -5% |
ANGO -8% |
Annual Revenue Growth | -3% | 11/14 | HOLX 30% |
ISRG 12% |
RMD 11% |
NVST 7% |
HAE 6% |
ICUI 6% |
MMSI 4% |
BDX 2% |
TFX 2% |
ATR 0% |
RGEN -3% |
WST -4% |
ANGO -9% |
COO -20% |
Cash On Hand | $784.0 Million | 5/14 | ISRG $2.4B |
HOLX $1.8B |
BDX $1.7B |
NVST $991.3M |
RGEN $784.0M |
MMSI $523.1M |
WST $490.9M |
RMD $426.4M |
ATR $325.5M |
HAE $320.8M |
ICUI $312.5M |
TFX $243.2M |
COO $107.6M |
ANGO $54.1M |
Short Term Debt | $12.2 Million | 9/14 | BDX $942.0M |
NVST $115.8M |
TFX $96.9M |
HOLX $53.4M |
ICUI $51.0M |
COO $33.3M |
ATR $30.3M |
WST $19.9M |
RGEN $12.2M |
MMSI $11.5M |
RMD $9.9M |
HAE $5.1M |
ISRG -$0 |
ANGO -$0 |
Long Term Debt | $660.3 Million | 10/14 | BDX $17.9B |
COO $2.6B |
TFX $1.8B |
ICUI $1.5B |
NVST $1.3B |
HAE $1.2B |
ATR $822.7M |
MMSI $750.5M |
RMD $667.6M |
RGEN $660.3M |
WST $284.9M |
HOLX $22.2M |
ISRG $0 |
ANGO $0 |
PE | -1.00 | 11/14 | ISRG 91.87 |
MMSI 52.32 |
COO 46.81 |
WST 46.72 |
BDX 37.57 |
TFX 32.93 |
RMD 31.22 |
ATR 28.05 |
HAE 23.68 |
HOLX 19.16 |
RGEN -1.00 |
ANGO -1.00 |
ICUI -1.00 |
NVST -1.00 |
PS | 13.90 | 2/14 | ISRG 26.19 |
RGEN 13.90 |
WST 8.11 |
RMD 7.23 |
COO 6.20 |
MMSI 4.74 |
HOLX 3.53 |
BDX 3.21 |
ATR 2.64 |
TFX 2.58 |
HAE 2.24 |
ICUI 1.64 |
ANGO 1.48 |
NVST 1.28 |
PB | 4.15 | 5/14 | ISRG 13.14 |
WST 8.48 |
RMD 6.69 |
MMSI 4.75 |
RGEN 4.15 |
ATR 3.69 |
HAE 3.40 |
HOLX 2.99 |
COO 2.27 |
ANGO 2.27 |
ICUI 1.88 |
TFX 1.74 |
BDX 1.69 |
NVST 1.17 |
PC | 10.68 | 10/14 | COO 170.65 |
ISRG 85.39 |
RMD 81.50 |
WST 47.55 |
BDX 37.77 |
TFX 32.14 |
ATR 28.95 |
ICUI 12.30 |
MMSI 12.01 |
RGEN 10.68 |
HAE 9.60 |
HOLX 8.00 |
ANGO 7.83 |
NVST 3.62 |
Liabilities to Equity | 0.40 | 10/14 | HAE 1.79 |
ICUI 1.10 |
HOLX 0.83 |
ATR 0.81 |
MMSI 0.80 |
NVST 0.79 |
TFX 0.67 |
ANGO 0.56 |
COO 0.52 |
RGEN 0.40 |
RMD 0.39 |
WST 0.34 |
BDX 0.33 |
ISRG 0.13 |
ROA | 0.00 | 11/14 | RMD 15% | WST 14% | ISRG 13% | HOLX 9% | ATR 7% | HAE 5% | MMSI 5% | BDX 3% | COO 3% | TFX 3% | RGEN 0% | ICUI -3% | NVST -24% | ANGO -77% |
ROE | 0.00 | 11/14 | RMD 21% |
WST 18% |
HOLX 16% |
ISRG 14% |
HAE 14% |
ATR 13% |
MMSI 9% |
COO 5% |
TFX 5% |
BDX 3% |
RGEN 0% |
ICUI -5% |
NVST -44% |
ANGO -120% |
Current Ratio | 3.48 | 4/14 | ISRG 8.59 |
WST 3.98 |
RMD 3.56 |
RGEN 3.48 |
BDX 3.03 |
COO 2.91 |
ANGO 2.78 |
TFX 2.49 |
NVST 2.26 |
MMSI 2.25 |
ATR 2.23 |
HOLX 2.21 |
ICUI 1.91 |
HAE 1.56 |
Quick Ratio | 0.96 | 2/14 | ISRG 91.87 |
MMSI 52.32 |
COO 46.81 |
WST 46.72 |
BDX 37.57 |
TFX 32.93 |
RMD 31.22 |
ATR 28.05 |
HAE 23.68 |
HOLX 19.16 |
RGEN -1.00 |
ANGO -1.00 |
ICUI -1.00 |
NVST -1.00 |
Long Term Debt to Equity | 0.33 | 6/14 | HAE} 1.35 |
ICUI} 0.75 |
MMSI} 0.57 |
NVST} 0.42 |
TFX} 0.39 |
RGEN} 0.33 |
COO} 0.32 |
ATR} 0.32 |
BDX} 0.31 |
RMD} 0.13 |
WST} 0.10 |
HOLX} 0.00 |
ISRG} 0.00 |
ANGO} 0.00 |
Debt to Equity | 0.33 | 6/14 | HAE 1.35 |
ICUI 0.78 |
MMSI 0.57 |
NVST 0.46 |
TFX 0.42 |
RGEN 0.33 |
BDX 0.33 |
COO 0.32 |
ATR 0.32 |
RMD 0.13 |
WST 0.11 |
HOLX 0.01 |
ISRG 0.00 |
ANGO 0.00 |
Burn Rate | 69.48 | 2/14 | MMSI 117.73 |
RGEN 69.48 |
HAE 25.53 |
NVST 13.58 |
ANGO 5.04 |
BDX 3.23 |
ICUI 2.91 |
RMD -1.51 |
WST -4.10 |
ISRG -4.27 |
ATR -5.47 |
HOLX -9.54 |
TFX -15.01 |
COO -15.03 |
Cash to Cap | 0.09 | 5/14 | NVST 0.28 |
HOLX 0.13 |
ANGO 0.13 |
HAE 0.10 |
RGEN 0.09 |
MMSI 0.08 |
ICUI 0.08 |
BDX 0.03 |
TFX 0.03 |
ATR 0.03 |
WST 0.02 |
ISRG 0.01 |
RMD 0.01 |
COO 0.01 |
CCR | -3.91 | 12/14 | NVST 7.72 |
TFX 2.76 |
WST 2.73 |
ISRG 2.63 |
ATR 1.54 |
MMSI 1.32 |
RMD 0.98 |
HAE 0.94 |
HOLX 0.86 |
ANGO -0.16 |
ICUI -0.65 |
RGEN -3.91 |
BDX |
COO |
EV to EBITDA | 1718.79 | 1/14 | RGEN} 1718.79 |
ICUI} 622.19 |
ISRG} 352.77 |
WST} 143.55 |
BDX} 126.18 |
COO} 105.03 |
MMSI} 88.49 |
TFX} 85.07 |
RMD} 79.36 |
NVST} 68.37 |
HAE} 67.49 |
HOLX} 35.57 |
ATR} 5.98 |
ANGO} -147.20 |
EV to Revenue | 13.72 | 2/14 | ISRG 25.89 |
RGEN 13.72 |
WST 8.05 |
RMD 7.28 |
COO 7.03 |
MMSI 4.91 |
BDX 4.06 |
TFX 3.12 |
HOLX 3.10 |
HAE 2.90 |
ATR 2.78 |
ICUI 2.19 |
NVST 1.43 |
ANGO 1.29 |